Insights On Solid Dose Manufacturing

  1. Tablets And Capsules: Overcoming Similar Obstacles In Production 7/30/2024

    Explore how understanding specific USP chapters can address common tablet and capsule production challenges and ensure high-quality results in this essential pharmaceutical process.

  2. Solvent-Free, Fusion-Based Amorphic Dispersion Process 7/11/2024

    Discover a solvent-free, fusion-based process that leverages frictional and shear forces to rapidly convert crystalline drugs and polymers into amorphous solid dispersions (ASDs).

  3. Functional Release Multiparticulates Slam 7/17/2024

    Review Adare Pharma Solutions’ innovative technologies and learn how these capabilities can improve patient outcomes and improve manufacturing efficiency.

  4. Key To Formulation Development Is In The Details 7/20/2023

    Find out how to face the challenges in tablet manufacturing environments through supportive vendor partnerships.

  5. How To Avoid Sticking And Picking In The Tableting Industry 9/23/2024

    Review strategies to mitigate sticking and picking risks in the tablet industry, and learn how you can foster improved tablet production processes, ensuring higher quality and consistency.

  6. Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates 7/17/2024

    Learn more about our orally disintegrating tablet (ODT) capabilities and how these innovative technologies have the potential to improve acceptance, adherence, and compliance in pharmacotherapy.

  7. Customized Release Through Dispersed Dosage Formats 6/13/2024

    Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.

  8. The Art And Science Of Pre-Picking Tablet Designs 7/30/2024

    Picking and sticking are the most common tablet defects that can reduce your product quality and performance. This makes perfecting the right pre-picking strategy essential to improving your processes.

  9. Innovations In Dosage Form Design Pediatrics & Patients With Dysphagia 7/17/2024

    With a focus on oral dosage form design for pediatrics and patients with dysphagia, Adare Pharma Solutions’ technologies and capabilities offer unique solutions to the pharmaceutical industry, ensuring improved drug delivery and patient experience.

  10. Closing The Duration Gap In FDA-Approved Long-Acting Contraceptives 7/17/2024

    A gap exists between three months and three years in FDA-approved long-acting contraceptives (LACs). A microsphere formulation enables sustained release over a six to twelve-month period.